The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has approved the GORE ® VIABAHN ® Endoprosthesis for interventional ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) announces that the first patients are now enrolled in the Gore RELINE MAX Clinical Study, a post-approval study to continue to ...
Notably, the Gore REVISE Clinical Study is the first AV access stent-graft study to include patients with thrombosed grafts and placement of the device across the elbow joint, further demonstrating ...
The EMBRACE Registry aims to evaluate safety and performance of the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis when used as a bridging stent with branched and fenestrated endografts in the ...
A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...
The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results